Outcome of Cytoreductive Surgery with HIPEC in Ovarian Versus Gastrointestinal Peritoneal Carcinomatosis: A 7-Year Single Centre Experience

Outcome of Cytoreductive Surgery with HIPEC in Ovarian Versus Gastrointestinal Peritoneal Carcinomatosis: A 7-Year Single Centre Experience

Saved in:

Bibliographic Details
Main Authors:	Mohamed E Ramadan, Emad M Abdelrahman, Youssef Abdel Zaher, Ahmed M Abostate
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações Ltda. 2025-06-01
Series:	Journal of Coloproctology
Subjects:	Peritoneal Carcinomatosis Peritoneal Carcinomatosis Index Cytoreductive surgery Hyperthermic Intraperitoneal Chemotherapy. Overall Survival Disease Free Survival
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809677
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PERITONEAL CARCINOMATOSIS. REVIEW OF WORLD EXPERIENCE
by: S. V. Solomenny, et al.
Published: (2017-02-01)

Gastric cancer: modern approaches and prospects of treatment for peritoneal carcinomatosis (literature review)
by: V. A. Markovich, et al.
Published: (2022-01-01)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
by: M. V. Zabelin, et al.
Published: (2022-06-01)

Peritoneal Carcinomatosis: Current State of the Art and Schools of Thought
by: Sh. Kh. Gantsev, et al.
Published: (2021-04-01)

Fluorescence Diagnostics and Photodynamic Therapy in Cytoreductive Surgical Treatment of Peritoneal Carcinomatosis Patient
by: D. A. Rudakov, et al.
Published: (2024-07-01)

The role of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in ovarian carcinoma: where do we stand today? A comprehensive review and clinical insights from a leading oncology center in India
by: M D Ray, et al.
Published: (2025-06-01)

Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects
by: Sh. Kh. Gantsev, et al.
Published: (2021-05-01)

Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy and intraoperative radiation therapy in the management of gastric cancer: a 10-year single center experience
by: Marwan M. Alaswad, et al.
Published: (2025-02-01)

MODERN STRATEGY IN TREATMENT OF PERITONEAL CARCINOMATOSIS
by: A. A. Zakharenko, et al.
Published: (2017-12-01)

EXPERIENCE IN APPLYING THE TECHNOLOGY OF CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
by: A. V. Shelekhov, et al.
Published: (2018-07-01)

SEPSIS DUE TO LISTERIA MONOCYTOGENES IN AN IMMUNOCOMPROMISED PATIENT WITH PERITONEAL CARCINOMATOSIS: A CASE REPORT
by: İrem Unat, et al.
Published: (2023-03-01)

Combined modality treatment of patients with stage IV gastric cancer with peritoneal carcinomatosis
by: V. A. Markovich, et al.
Published: (2023-02-01)

Intraoperative photodynamic therapy and hyperthermic intraperitoneal chemotherapy in cytoreductive treatment of patients with disseminated mucinous carcinoma of appendix
by: D. V. Sidorov, et al.
Published: (2021-02-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience
by: Burak Dinçer, et al.
Published: (2025-03-01)

Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines
by: Expert Panel Management of Peritoneal Carcinomatosis, et al.
Published: (2025-07-01)

Peritoneal Carcinomatosis in Patients with Locally Advanced Colon Cancer: Literature Review
by: S. Yu. Trishchenkov, et al.
Published: (2025-08-01)

Feasibility of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program for Gastrointestinal and Gynecological Cancer Care in Newfoundland and Labrador
by: Kala Hickey, et al.
Published: (2025-04-01)

Pressurized intraperitoneal aerosolized chemotherapy clinical efficacy in the combined treatment of newly diagnosed ovarian cancer with peritoneal carcinomatosis and ascites
by: A. S. Dzasochov, et al.
Published: (2024-12-01)

CYTOREDUCTIVE SURGICAL TREATMENT WITH INTRAOPERATIVE PHOTODYNAMIC THERAPY IN PATIENTS WITH MUCINOUS PERITONEAL CARCINOMATOSIS
by: N. A. Grishin, et al.
Published: (2017-12-01)

PERITONEAL CARCINOMATOSIS
by: I. V. Stepanov, et al.
Published: (2016-02-01)

When Peritoneal Tuberculosis Mimics Carcinomatosis: A Diagnostic Enigma
by: Margarida Soares Resendes, et al.
Published: (2025-04-01)

PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY COMBINED WITH SYSTEM CHEMOTHERAPY – A NEW APPROACH TO TREATMENT OF GASTRIC CANCER PATIENTS WITH PERITONAL CARCINOMATOSIS
by: V. M. Khomyakov, et al.
Published: (2020-09-01)

State-of-the-Art Therapy in Peritoneal Carcinomatosis Management
by: Elbek Fozilov, et al.
Published: (2025-04-01)

Outcomes and prognostic factors of cytoreductive surgery and perioperative intraperitoneal chemotherapy in high-volume peritoneal carcinomatosis
by: Lee S. Kyang, et al.
Published: (2022-12-01)

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Youngbae Jeon, et al.
Published: (2023-12-01)

Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases
by: Raymond Hayler, et al.
Published: (2025-07-01)

Ascitic ovarian cancer is an adequate preclinical model of carcinomatosis to study intraperitoneal chemoperfusion treatment
by: G. S. Kireeva, et al.
Published: (2019-02-01)

Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes
by: Mehdi Karimi, et al.
Published: (2024-12-01)

Perspectives of pressurized intraperitoneal aerosol chemotherapy in terms of primary ovarian cancer with peritoneal carcinomatosis treatment
by: A. S. Dzasokhov, et al.
Published: (2023-03-01)

Prognostic value of neutrophil-to-lymphocyte ratio and CA 19–9 in overall survival of patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Yanli Nie, et al.
Published: (2025-06-01)

The effect of Pressurised Intraperitoneal Aerosol Chemotherapy on the quality of life of patients with primary diagnosed ovarian cancer with peritoneal carcinomatosis during combined treatment
by: A. S. Dzasokhov, et al.
Published: (2023-03-01)

Prognostic importance of the neutrophil-to-lymphocyte ratio in malignant peritoneal mesothelioma patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Zhang Xinjing, et al.
Published: (2025-02-01)

Dynamic assessment of intraperitoneal aerosol chemotherapy under pressure impact on peritoneal carcinomatosis in ovarian cancer (immediate results)
by: A. S. Dzasokhov, et al.
Published: (2023-03-01)

The effect of pressurized intraperitoneal aerosolized chemotherapy on the surgical treatment outcomes of ovarian cancer with peritoneal carcinomatosis
by: A. S. Dzasochov, et al.
Published: (2024-06-01)

Cytoreductive surgery and hyperthermal intraperitoneal chemoperfusion in colorectal cancer and cancer of ovaries: our experience and perspectives of a new method
by: A. V. Malynovskyi, et al.
Published: (2020-10-01)

The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis
by: Ángela Bella, et al.
Published: (2023-12-01)

Diagnostic Challenges and Multimodal Treatment in Primary Peritoneal Cancer: a Case Report
by: Alina POTORAC, et al.
Published: (2024-12-01)

New views on pathogenesis and diagnosis of peritoneal carcinomatosis
by: K. R. Ishmuratova, et al.
Published: (2023-01-01)

Voluminous bilateral malignant ovarian germ cell tumors with carcinomatosis in a child
by: Nadia Boujida, et al.
Published: (2025-09-01)

High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies
by: Louis Choon Kit Wong, et al.
Published: (2022-12-01)